Heterochromatin: Stable and unstable invasions at home and abroad

Genes and Development

Volumn 17, Issue 15, 2003, Pages 1805-1812

  Fahrner, Jill A ^a   Baylin, Stephen B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

REPETITIVE DNA;

CHROMOSOME; DNA METHYLATION; DNA SEQUENCE; EUCHROMATIN; GENE LOCATION; GENE LOSS; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENE TRANSFER; GENE TRANSLOCATION; GENETIC LINKAGE; GENETIC STABILITY; HETEROCHROMATIN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REPORTER GENE; REVIEW; STEADY STATE; SUPPRESSOR GENE; X IRRADIATION;

EID: 0042626332     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1123303     Document Type: Review

References (66)

1. Ahmad, K. and Henikoff, S. 2002a. Epigenetic consequences of nucleosome dynamics. Cell 111: 281-284.
2. -. 2002b. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol. Cell 9: 1191-1200.
3. Ayyanathan, K., Lechner, M.S., Bell, P., Maul, G.G., Schultz, D.C., Yamada, Y., Tanaka, K., Torigoe, K., and Rauscher III, F.J. 2003. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: A mammalian cell culture model of gene variegation. Genes & Dev. (this issue).
4. Bachman, K.E., Rountree, M.R., and Baylin, S.B. 2001. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276: 32282-32287.
5. Bachman, K.E., Park, B.H., Rhee, I., Rajagopalan, H., Herman, J.G., Baylin, S.B., Kinzler, K.W., and Vogelstein, B. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89-95.
6. Bannister, A.J., Schneider, R., and Kouzarides, T. 2002. Histone methylation: Dynamic or static? Cell 109: 801-806.
7. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes & Dev. 16:6-21.
8. Boggs, B.A., Cheung, P., Heard, E., Spector, D.L., Chinault, A.C., and Allis, C.D. 2002. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat. Genet. 30: 73-76.
9. Burgers, W.A., Fuks, F., and Kouzarides, T. 2002. DNA methyltransferases get connected to chromatin. Trends Genet. 18: 275-277.
10. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., and Baylin, S.B. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21: 103-107.
11. Csankovszki, G., Nagy, A., and Jaenisch, R. 2001. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol. 153: 773-784.
12. Datta, J., Ghoshal, K., Sharma, S.M., Tajima, S., and Jacob, S.T. 2003. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. J. Cell Biochem. 88: 855-864.
13. De Matzo, A.M., Marchi, V.L., Yang, E.S., Veeraswamy, R., Lin, X., and Nelson, W.G. 1999. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59: 3855-3860.
14. Deplus, R., Brenner, C., Burgers, W.A., Putmans, P., Kouzarides, T., de Launoit, Y., and Fuks, F. 2002. Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 30: 3831-3838.
15. Eissenberg, J.C. and Elgin, S.C. 2000. The HP1 protein family: Getting a grip on chromatin. Curr. Opin. Genet. Dev. 10: 204-210.
16. Fahrner, J.A., Eguchi, S., Herman, J.G., and Baylin, S.B. 2002. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62: 7213-7218.
17. Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24: 88-91.
18. Fuks, F., Hurd, P.J., Deplus, R., and Kouzarides, T. 2003. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31: 2305-2312.
19. Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X., Parthun, M., and Jacob, S.T. 2002. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol. Cell. Biol. 22: 8302-8319.
20. Graff, J.R., Gabrielson, E., Fujii, H., Baylin, S.B., and Herman, J.G. 2000. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275: 2727-2732.
21. Grewal, S.I. and Elgin, S.C. 2002. Heterochromatin: New possibilities for the inheritance of structure. Curr. Opin. Genet. Dev. 12: 178-187.
22. Hall, I.M., Shankaranarayana, G.D., Noma, K., Ayoub, N., Cohen, A., and Grewal, S.I. 2002. Establishment and maintenance of a heterochromatin domain. Science 297: 2232-2237.
23. Hwang, K.K., Eissenberg, J.C., and Worman, H.J. 2001. Transcriptional repression of euchromatic genes by Drosophila heterochromatin protein 1 and histone modifiers. Proc. Natl. Acad. Sci. 98: 11423-11427.
24. Issa, J.P., Vertino, P.M., Wu, J., Sazawal, S., Celano, P., Nelkin, B.D., Hamilton, S.R., and Baylin, S.B. 1993. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst. 85: 1235-1240.
25. Jackson, J.P., Lindroth, A.M., Cao, X., and Jacobsen, S.E. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416: 556-560.
26. Jacobs, S.A., Taverna, S.D., Zhang, Y., Briggs, S.D., Li, J., Eissenberg, J.C., Allis, C.D., and Khorasanizadeh, S. 2001. Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. EMBO J. 20: 5232-5241.
27. Jenuwein, T. 2001. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol. 11: 266-273.
28. Jenuwein, T. and Allis, C.D. 2001. Translating the histone code. Science 293: 1074-1080.
29. Johnson, L., Cao, X., and Jacobsen, S. 2002. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol. 12: 1360-1367.
30. Jones, P.A. and Baylin, S.B. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
31. Kimura, A., Umehara, T., and Horikoshi, M. 2002. Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat. Genet. 32: 370-377.
32. Kondo, Y., Shen, L., and Issa, J.P. 2003. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23: 206-215.
33. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12: 198-209.
34. Lachner, M. and Jenuwein, T. 2002. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14: 286-298.
35. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., and Jenuwein, T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120.
36. Li, Y., Kirschmann, D.A., and Wallrath, L.L. 2002. Does heterochromatin protein 1 always follow code? Proc. Natl. Acad. Sci. 99: (Suppl. 4) 16462-16469.
37. Litt, M.D., Simpson, M., Gaszner, M., Allis, C.D., and Felsenfeld, G. 2001. Correlation between histone lysine methylation and developmental changes at the chicken β-globin locus. Science 293: 2453-2455.
38. Lunyak, V.V., Burgess, R., Prefontaine, G.G., Nelson, C., Sze, S.H., Chenoweth, J., Schwartz, P., Pevzner, P.A., Glass, C., Mandel, G., et al. 2002. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298: 1747-1752.
39. Maison, C., Bailly, D., Peters, A.H., Quivy, J.P., Roche, D., Taddei, A., Lachner, M., Jenuwein, T., and Almouzni, G. 2002. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 30: 329-334.
40. Nakayama, J., Rice, J.C., Strahl, B.D., Allis, C.D., and Grewal, S.I. 2001. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292: 110-113.
41. Nguyen, C.T., Weisenberger, D.J., Velicescu, M., Gonzales, F.A., Lin, J.C., Liang, G., and Jones, P.A. 2002. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62: 6456-6461.
42. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., et al. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561-565.
43. Noma, K., Allis, C.D., and Grewal, S.I. 2001. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 293: 1150-1155.
44. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337.
45. Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., Otte, A.P., Panning, B., and Zhang, Y. 2003. Role of histone H3 lysine 27 methylation in X inactivation. Science 300: 131-135.
46. Rhee, I., Bachman, K.E., Park, B.H., Jair, K.W., Yen, R.W., Schuebel, K.E., Cui, H., Feinberg, A.P., Lengauer, C., Kinzler, K.W., et al. 2002. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556.
47. Richards, E.J. and Elgin, S.C. 2002. Epigenetic codes for heterochromatin formation and silencing: Rounding up the usual suspects. Cell 108: 489-500.
48. Robertson, K.D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F.A., and Jones, P.A. 1999. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27: 2291-2298.
49. Robertson, K.D., Ait-Si-Ali, S., Yokochi, T., Wade, P.A., Jones, P.L., and Wolffe, A.P. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25: 338-342.
50. Rountree, M.R., Bachman, K.E., and Baylin, S.B. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25: 269-277.
51. Schultz, D.C., Friedman, J.R., and Rauscher III, F.J. 2001. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: The PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2α subunit of NuRD. Genes & Dev. 15: 428-443.
52. Schultz, D.C., Ayyanathan, K., Negorev, D., Maul, G.G., and Rauscher III, F.J. 2002. SETDBI: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes & Dev. 16: 919-932.
53. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
54. Strahl, B.D., and Allis, C.D. 2000. The language of covalent histone modifications. Nature 403: 41-45.
55. Suka, N., Luo, K., and Grunstein, M. 2002. Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin. Nat. Genet. 32: 378-383.
56. Sun, F.L. and Elgin, S.C. 1999. Putting boundaries on silence. Cell 99: 459-462.
57. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G., and Baylin, S.B. 2002. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31: 141-149.
58. Tamaru, H. and Selker, E.U. 2001. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414: 277-283.
59. Tilghman, S.M. 1999. The sins of the fathers and mothers: Genomic imprinting in mammalian development. Cell 96: 185-193.
60. Tufarelli, C., Stanley, J.A., Garrick, D., Sharpe, J.A., Ayyub, H., Wood, W.G., and Higgs, D.R. 2003. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet. 34: 157-165.
61. Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., Ghosh, D., Pienta, K.J., Sewalt, R.G., Otte, A.P., et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.
62. Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., and Martienssen, R.A. 2002. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297: 1833-1837.
63. Wakimoto, B.T. 1998. Beyond the nucleosome: Epigenetic aspects of position-effect variegation in Drosophila. Cell 93: 321-324.
64. Wallrath, L.L. and Elgin, S.C. 1995. Position effect variegation in Drosophila is associated with an altered chromatin structure. Genes & Dev. 9: 1263-1277.
65. Willard, H.F. and Carrel, L. 2001. Making sense (and antisense) of the X inactivation center. Proc. Natl. Acad. Sci. 98: 10025-10027.
66. Xin, Z., Tachibana, M., Guggiari, M., Heard, E., Shinkai, Y., and Wagstaff, J. 2003. Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. J. Biol. Chem. 278: 14996-15000.